Mercedes-Benz Q1 profit falls 17% as China sales slump outweigh U.S. gains

Mercedes-Benz reported first-quarter net profit of €1.43 billion, down 17.2% year over year, as revenue fell 5% to €31.60 billion and adjusted EBIT dropped 30% to €1.77 billion. China sales declined 27% to 111,621 units, offsetting gains in the U.S. and in BEVs, which rose 9% to 44,258 units. The company reaffirmed 2026 guidance and highlighted ongoing restructuring, including the sale of Athlon Group and additional German retail operations.

Analysis

The key signal is not the headline profit miss; it is the divergence between cash generation and operating earnings. That combination usually marks a late-cycle OEM where pricing power is decaying faster than industrial balance-sheet optionality, which means equity downside can be buffered for a while even as the earnings power resets lower over the next 2-3 quarters. The market should focus on whether the China volume decline is purely a product-cycle issue or the beginning of a more durable share loss to local premium EV brands, because the latter would compress terminal multiples materially.

The balance-sheet strength and guidance reaffirmation reduce immediate solvency risk, but they also increase the likelihood of continued capital allocation toward restructuring rather than aggressive growth investment. That is a subtle negative for near-term margin recovery: selling retail assets and shrinking non-core exposure can improve optics and cash, yet it often masks a structurally lower revenue base and limits upside from an eventual China rebound. The stronger U.S. and BEV performance are helpful, but they are not yet large enough to offset a China mix deterioration if that trend persists into the summer selling season.

Second-order implications matter for suppliers and peers: a premium OEM under pressure tends to push the burden of discounting and inventory risk down the chain, which can squeeze high-end components, logistics, and dealer groups before it shows up in headline industry data. The contrarian point is that the equity may already be pricing in a worse China outcome than management is willing to acknowledge, so the immediate short may be crowded; the cleaner catalyst is a second consecutive quarter of China unit weakness or softer guidance on EBIT margin rather than the current print alone.

Key Decisions for Investors

• Avoid chasing the stock lower immediately; wait for a failed bounce or a 2Q demand update before adding shorts, since the cash-flow profile can support near-term multiple stability over the next 4-8 weeks.
• If accessible, pair long BMW.DE vs short MBG.DE over the next 1-3 months: MBG has more China sensitivity and a more fragile premium mix, while BMW's relative product cadence and geographic diversification may hold up better if China remains soft.
• Buy short-dated downside protection on MBG.DE into the next catalyst window (next earnings / China sales data): 3-6 month put spreads offer better convexity than outright shorting given the balance-sheet cushion.
• Short the most exposed premium auto suppliers or dealer-adjacent names on any strength if China weakness persists: the second-order inventory and discounting pressure often hits suppliers with a 1-2 quarter lag.
• For investors needing exposure to European autos, prefer a relative-value basket long OEMs with stronger U.S./hybrid mix and lower China concentration; the setup favors dispersion rather than outright sector beta.